Latest On Replimune Group, Inc (REPL):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-18 10:06 EST | News | Replimune Group GAAP EPS of -$2.99 | N/A |  |
| 2023-03-09 21:29 EST | News | Replimune: A Sell Ahead Of Cutaneous Squamous Cell Carcinoma Data | N/A | |
| 2023-02-27 18:58 EST | News | Replimune ends selloff after FDA response to mid-stage cancer trial | N/A | |
| 2023-02-09 15:01 EST | News | Replimune Group GAAP EPS of -$0.69 beats by $0.08 | N/A | |
| 2022-12-09 23:21 EST | News | Revisiting Replimune | N/A | |
| 2022-12-09 06:08 EST | News | Replimune prices ~$225M of securities offering | N/A | |
| 2022-12-07 19:48 EST | News | Replimune in pact with Roche to study cancer drug combos | N/A | |
| 2022-12-07 19:47 EST | News | Replimune announces proposed public offering of up to $125M | N/A | |
| 2022-11-03 14:30 EST | News | Replimune Group GAAP EPS of -$0.79 misses by $0.01 | N/A | |
| 2022-10-07 20:24 EST | News | Replimune secures $200M term loan | N/A | |
| 2022-08-13 00:15 EST | News | Replimune: Recent Developments Strengthen Bull Thesis | N/A | |
| 2022-08-04 15:54 EST | News | Replimune Group GAAP EPS of -$0.78 misses by $0.15 | N/A | |
| 2022-05-20 04:01 EST | News | Replimune Group GAAP EPS of -$2.26 beats by $0.02 | N/A | |
| 2022-02-03 16:39 EST | News | Replimune Group GAAP EPS of -$0.57 beats by $0.01 | N/A | |
| 2022-01-13 03:38 EST | News | Replimune (REPL) Presents At 40th Annual J.P. Morgan Virtual Healthcare Conference | N/A | |
| 2021-11-04 15:14 EST | News | Replimune Group EPS misses by $0.01 | N/A | |
| 2021-10-01 20:17 EST | News | Replimune: In The 'Buy Zone' Again | N/A | |
| 2021-08-07 05:42 EST | News | Replimune sheds over 10% after earnings miss; BMO trims price target | N/A | |
| 2021-08-06 09:21 EST | News | Replimune Group EPS misses by $0.08 | N/A | |
| 2021-07-21 21:36 EST | News | Replimune climbs on promising Phase 2 data for skin cancer therapy | N/A | |
| 2021-07-21 21:36 EST | News | Replimune shares down 14% following phase 2 skin cancer drug data | N/A | |
| 2021-07-21 21:35 EST | News | Merck spinoff closes higher despite neutral views; Mirati gains on Citi upgrade; more in today’s analyst action | N/A | |
| 2021-07-21 21:35 EST | News | Buy The Replimune Dip Caused By Unrealistic Expectations | N/A | |
| 2021-05-05 22:04 EST | News | Replimune shares rise 9% following positive clinical trial updates for lead candidate | N/A | |
| 2021-04-30 17:41 EST | News | Replimune: Oncolytic Immunotherapy Pioneer Gaining Momentum In The Clinic | N/A | |
| 2021-04-13 01:05 EST | News | Replimune presents promising data on lead programs RP1 and RP2 | N/A | |
| 2021-02-10 08:20 EST | Analyst Rating | The Analyst Target Price has increased from $55.6 to $56.3. | Buy | |
| 2021-02-06 04:19 EST | Financials | Company financials have been released. | Neutral | |
| 2021-02-05 08:41 EST | Earnings Estimate | An EPS average of -$0.47 is estimated for the quarter ending on June 30, 2021. | Sell | |
| 2021-02-05 08:41 EST | Analyst Rating | The Analyst Target Price has decreased from $55.7 to $55.6. | Neutral | |
| 2021-02-04 20:09 EST | News | Replimune Group EPS misses by $0.03 | N/A | |
| 2021-01-20 22:45 EST | News | Replimune (REPL) Presents At 39th Annual J.P. Morgan Healthcare Conference - Slideshow | N/A | |
| 2021-01-05 19:45 EST | News | Dosing underway in Replimune's early-stage cancer study with gene therapy | N/A | |
| 2020-12-06 09:07 EST | News | Replimune: Interesting Developer Of Oncolytic Immunotherapies | N/A | |
| 2020-11-26 21:21 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-18 13:07 EST | Analyst Rating | The Analyst Target Price has increased from $55.22 to $55.7. | Buy | |
| 2020-11-11 12:50 EST | Analyst Rating | The Analyst Target Price has increased from $54.78 to $55.22. | Buy | |
| 2020-11-09 13:13 EST | Analyst Rating | The Analyst Target Price has increased from $53.44 to $54.78. | Buy | |
| 2020-11-08 00:44 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 16:58 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-06 08:44 EST | Analyst Rating | The Analyst Target Price has increased from $51.33 to $53.44. | Buy | |
| 2020-11-05 13:32 EST | News | Replimune Group EPS misses by $0.02 | N/A | |
| 2020-11-03 08:52 EST | Analyst Rating | The Analyst Target Price has increased from $49.38 to $51.33. | Buy | |
| 2020-10-30 14:28 EST | Analyst Rating | The Analyst Target Price has increased from $38.63 to $49.38. | Buy | |
| 2020-10-23 06:27 EST | News | Replimune prices upsized equity offering | N/A | |
| 2020-10-21 03:30 EST | News | Replimune readies $125M equity offering | N/A | |
| 2020-10-16 18:11 EST | Insider Trade | Pamela Esposito has directly disposed of 9,000 shares and currently holds 112,700 shares. | Sell | |
| 2020-10-16 18:11 EST | Insider Trade | Pamela Esposito has directly disposed of 7,000 shares and currently holds 121,700 shares. | Sell | |
| 2020-10-16 18:11 EST | Insider Trade | Pamela Esposito has directly acquired 16,000 shares and currently holds 128,700 shares. | Buy | |
| 2020-10-15 05:28 EST | Analyst Rating | The Analyst Target Price has increased from $30.75 to $38.63. | Buy | |
About Replimune Group, Inc (REPL):
Replimune Group, Inc., a biotechnology company, develops oncolytic immune-gene therapies to treat cancer. It uses its proprietary Immulytic platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes simplex virus 1, which is in Phase I/II clinical trials for a range of solid tumors; and that is in Phase II clinical trials for patients with cutaneous squamous cell carcinoma. It is also developing RP2, which is in Phase I clinical trials for an anti-CTLA-4 antibody-like protein in order to block the inhibition of the immune response otherwise caused by CTLA-4; and RP3 to express immune-activating proteins that stimulate T cells. Replimune Group, Inc. was founded in 2015 and is headquartered in Woburn, Massachusetts.
General
- Name Replimune Group, Inc
- Symbol REPL
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 122
- Fiscal Year EndMarch
- IPO Date2018-07-20
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://replimune.com
View More
Valuation
- Price/Book (Most Recent Quarter) 3.14
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$1.78
- Next Year EPS Estimate -$1.89
- Next Quarter EPS Estimate -$0.42
- Return on Assets -11%
- Return on Equity -21%
- Earnings Per Share -$1.01
- Revenue Per Share $0
- Quarterly Earnings Growth 0%
View More
Highlights
- Market Capitalization 1.57 billion
- EBITDA -33106000
- Analyst Target Price $56.3
- Book Value Per Share $11.13
View More
Share Statistics
- Shares Outstanding 46.49 million
- Shares Float 25.11 million
- % Held by Insiders 941%
- % Held by Institutions 77.93%
- Shares Short 2.48 million
- Shares Short Prior Month 2.62 million
- Short Ratio 6.93
- Short % of Float 11%
- Short % of Shares Outstanding 5%
View More
Technicals
- Beta 2.6
- 52 Week High $54.85
- 52 Week Low $8.58
- 50 Day Moving Average 36.65
- 200 Day Moving Average 37.57
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Replimune Group, Inc (REPL) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Replimune Group, Inc (REPL) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-02-04 | $N/A | -$0.42 | -$0.41 | -3.22% |
| 2020-09-30 | 2020-11-05 | $N/A | -$0.46 | -$0.44 | -5.34% |
| 2020-06-30 | 2020-08-07 | $N/A | -$0.44 | -$0.43 | -1.31% |
| 2020-03-31 | 2020-06-03 | $N/A | -$0.41 | -$0.43 | 5.7% |
| 2019-12-31 | 2020-02-13 | $N/A | -$0.46 | -$0.36 | -26.55% |
| 2019-09-30 | 2019-11-11 | $N/A | -$0.35 | -$0.34 | -3.73% |
| 2019-06-30 | 2019-08-14 | $N/A | -$0.30 | -$0.31 | 3.97% |
| 2019-03-31 | 2019-06-28 | $N/A | -$0.15 | -$0.42 | 64.06% |
| 2018-12-31 | 2019-02-14 | $N/A | -$0.24 | -$0.25 | 2.12% |
| 2018-09-30 | 2018-11-14 | $N/A | -$0.26 | -$0.20 | -33.33% |
| 2018-06-30 | 2018-08-30 | $N/A | -$0.42 | -$0.21 | -98.1% |
Replimune Group, Inc (REPL) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Replimune Group, Inc (REPL) Chart:
Replimune Group, Inc (REPL) News:
Below you will find a list of latest news for Replimune Group, Inc (REPL) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Replimune Group, Inc (REPL) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2024-05-17 | 2.5 | 6.1 | CALL | 0 | 12 | 436.31 | TRUE | 0 | 0 |
| 2024-05-17 | 5 | 3.74 | CALL | 0 | 5 | 279.05 | TRUE | 0 | 0 |
| 2024-05-17 | 7.5 | 0.55 | CALL | 0 | 24 | 87.55 | FALSE | 0 | 0 |
| 2024-05-17 | 10 | 0.12 | CALL | 0 | 105 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 12.5 | 0.2 | CALL | 0 | 190 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 15 | 0.15 | CALL | 0 | 69 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 17.5 | 0.05 | CALL | 0 | 10 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 20 | 0.12 | CALL | 0 | 63 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 22.5 | 0.1 | CALL | 0 | 15 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 25 | 0.1 | CALL | 0 | 8 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 30 | 1.2 | CALL | 0 | 475 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 35 | 1.2 | CALL | 0 | 44 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 40 | 0.8 | CALL | 0 | 4 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 2.5 | 0.1 | PUT | 0 | 2 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 5 | 0.1 | PUT | 0 | 66 | 0 | FALSE | 0 | 0 |
| 2024-05-17 | 7.5 | 1.22 | PUT | 70 | 554 | 119.23 | TRUE | 1.22 | 0 |
| 2024-05-17 | 10 | 2.47 | PUT | 0 | 118 | 206.25 | TRUE | 0 | 0 |
| 2024-05-17 | 12.5 | 4.53 | PUT | 0 | 50 | 425.15 | TRUE | 0 | 0 |
| 2024-05-17 | 15 | 6.2 | PUT | 0 | 1 | 305.12 | TRUE | 0 | 0 |
| 2024-05-17 | 17.5 | 10.55 | PUT | 0 | 2 | 336.2 | TRUE | 0 | 0 |
| 2024-05-17 | 20 | 8.8 | PUT | 0 | 0 | 346.5 | TRUE | 0 | 0 |
| 2024-05-17 | 22.5 | 0 | PUT | 0 | 0 | 383.96 | TRUE | 0 | 0 |
| 2024-05-17 | 25 | 0 | PUT | 0 | 0 | 403.13 | TRUE | 0 | 0 |
| 2024-05-17 | 30 | 0 | PUT | 0 | 0 | 435.3 | TRUE | 0 | 0 |
| 2024-05-17 | 35 | 0 | PUT | 0 | 0 | 419.34 | TRUE | 0 | 0 |
| 2024-05-17 | 40 | 0 | PUT | 0 | 0 | 690.83 | TRUE | 0 | 0 |
| 2024-06-21 | 2.5 | 0 | CALL | 0 | 0 | 228.47 | TRUE | 0 | 0 |
| 2024-06-21 | 5 | 0 | CALL | 0 | 0 | 162.86 | TRUE | 0 | 0 |
| 2024-06-21 | 7.5 | 0 | CALL | 0 | 0 | 242.38 | FALSE | 0 | 0 |
| 2024-06-21 | 10 | 0 | CALL | 0 | 0 | 288.06 | FALSE | 0 | 0 |
| 2024-06-21 | 12.5 | 0 | CALL | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-06-21 | 5 | 0 | PUT | 0 | 0 | 158.52 | FALSE | 0 | 0 |
| 2024-06-21 | 7.5 | 0 | PUT | 0 | 0 | 201.06 | TRUE | 0 | 0 |
| 2024-06-21 | 10 | 0 | PUT | 0 | 0 | 90.28 | TRUE | 0 | 0 |
| 2024-06-21 | 12.5 | 0 | PUT | 0 | 0 | 295.96 | TRUE | 0 | 0 |
| 2024-08-16 | 2.5 | 5.77 | CALL | 0 | 1 | 275.54 | TRUE | 0 | 0 |
| 2024-08-16 | 5 | 4.25 | CALL | 0 | 8 | 50.58 | TRUE | 0 | 0 |
| 2024-08-16 | 7.5 | 1.15 | CALL | 0 | 156 | 81.23 | FALSE | 0 | 0 |
| 2024-08-16 | 10 | 0.75 | CALL | 0 | 48 | 80.92 | FALSE | 0 | 0 |
| 2024-08-16 | 12.5 | 0.6 | CALL | 0 | 97 | 131.95 | FALSE | 0 | 0 |
| 2024-08-16 | 15 | 0.55 | CALL | 0 | 2 | 109.88 | FALSE | 0 | 0 |
| 2024-08-16 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-08-16 | 5 | 0.3 | PUT | 0 | 320 | 83.71 | FALSE | 0 | 0 |
| 2024-08-16 | 7.5 | 1.57 | PUT | 0 | 99 | 78.83 | TRUE | 0 | 0 |
| 2024-08-16 | 10 | 3.1 | PUT | 0 | 43 | 115.19 | TRUE | 0 | 0 |
| 2024-08-16 | 12.5 | 0 | PUT | 0 | 0 | 125.57 | TRUE | 0 | 0 |
| 2024-08-16 | 15 | 0 | PUT | 0 | 0 | 152.9 | TRUE | 0 | 0 |
| 2024-11-15 | 2.5 | 0 | CALL | 0 | 0 | 302.94 | TRUE | 0 | 0 |
| 2024-11-15 | 5 | 0 | CALL | 0 | 0 | 74.29 | TRUE | 0 | 0 |
| 2024-11-15 | 7.5 | 2.6 | CALL | 0 | 2 | 108.47 | FALSE | 0 | 0 |
| 2024-11-15 | 10 | 1.3 | CALL | 0 | 1 | 87.31 | FALSE | 0 | 0 |
| 2024-11-15 | 12.5 | 1.55 | CALL | 0 | 10 | 111.89 | FALSE | 0 | 0 |
| 2024-11-15 | 15 | 0 | CALL | 0 | 0 | 91.55 | FALSE | 0 | 0 |
| 2024-11-15 | 17.5 | 1.1 | CALL | 0 | 2 | 114.09 | FALSE | 0 | 0 |
| 2024-11-15 | 2.5 | 0 | PUT | 0 | 0 | 0 | FALSE | 0 | 0 |
| 2024-11-15 | 5 | 0 | PUT | 0 | 0 | 161.62 | FALSE | 0 | 0 |
| 2024-11-15 | 7.5 | 2.24 | PUT | 75 | 1 | 97.67 | TRUE | 2.24 | 0 |
| 2024-11-15 | 10 | 0 | PUT | 0 | 0 | 111.81 | TRUE | 0 | 0 |
| 2024-11-15 | 12.5 | 5.1 | PUT | 0 | 2 | 63.53 | TRUE | 0 | 0 |
| 2024-11-15 | 15 | 0 | PUT | 0 | 0 | 123.13 | TRUE | 0 | 0 |
| 2024-11-15 | 17.5 | 0 | PUT | 0 | 0 | 116.5 | TRUE | 0 | 0 |
Latest REPL Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 79 | $14.615 |
| Jun 13, 2022 7:59 PM EST | 77 | $14.615 |
| Jun 13, 2022 7:59 PM EST | 100 | $14.615 |
| Jun 13, 2022 7:59 PM EST | 100 | $14.615 |
| Jun 13, 2022 7:59 PM EST | 100 | $14.615 |
Replimune Group, Inc (REPL) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-07-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737953/000110465920079316/0001104659-20-079316-index.htm |
| 2019-08-06 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1737953/000000000019012032/0000000000-19-012032-index.htm |
| 2019-08-08 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1737953/000000000019012229/0000000000-19-012229-index.htm |
| 2019-08-12 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1737953/000000000019012322/0000000000-19-012322-index.htm |
| 2020-08-13 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/1737953/000000000020007415/0000000000-20-007415-index.htm |
| 2018-07-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000089924318020583/0000899243-18-020583-index.htm |
| 2018-07-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000089924318020659/0000899243-18-020659-index.htm |
| 2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000089924319009840/0000899243-19-009840-index.htm |
| 2020-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000089924320010144/0000899243-20-010144-index.htm |
| 2019-03-26 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1737953/000092189519000888/0000921895-19-000888-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1737953/000092189520000522/0000921895-20-000522-index.htm |
| 2019-06-28 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1737953/000104746919003946/0001047469-19-003946-index.htm |
| 2019-07-29 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/1737953/000104746919004416/0001047469-19-004416-index.htm |
| 2019-08-07 | PRER14A | Preliminary Proxy Soliciting materials | https://www.sec.gov/Archives/edgar/data/1737953/000104746919004603/0001047469-19-004603-index.htm |
| 2019-08-08 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1737953/000104746919004650/0001047469-19-004650-index.htm |
| 2019-08-09 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1737953/000104746919004672/0001047469-19-004672-index.htm |
| 2019-11-12 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1737953/000104746919006246/0001047469-19-006246-index.htm |
| 2019-11-18 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1737953/000104746919006347/0001047469-19-006347-index.htm |
| 2020-06-03 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1737953/000104746920003318/0001047469-20-003318-index.htm |
| 2020-06-08 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1737953/000104746920003424/0001047469-20-003424-index.htm |
| 2020-06-10 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1737953/000104746920003511/0001047469-20-003511-index.htm |
| 2020-07-29 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1737953/000104746920004296/0001047469-20-004296-index.htm |
| 2018-07-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465918047445/0001104659-18-047445-index.htm |
| 2018-07-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465918047446/0001104659-18-047446-index.htm |
| 2018-07-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465918047447/0001104659-18-047447-index.htm |
| 2018-07-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465918047449/0001104659-18-047449-index.htm |
| 2018-07-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465918047451/0001104659-18-047451-index.htm |
| 2018-07-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465918047452/0001104659-18-047452-index.htm |
| 2018-07-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465918047453/0001104659-18-047453-index.htm |
| 2018-07-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465918047454/0001104659-18-047454-index.htm |
| 2018-07-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465918047455/0001104659-18-047455-index.htm |
| 2018-07-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465918047456/0001104659-18-047456-index.htm |
| 2018-07-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465918047457/0001104659-18-047457-index.htm |
| 2018-07-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465918047458/0001104659-18-047458-index.htm |
| 2018-07-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465918047459/0001104659-18-047459-index.htm |
| 2018-07-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465918047460/0001104659-18-047460-index.htm |
| 2018-07-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737953/000110465918048142/0001104659-18-048142-index.htm |
| 2018-08-30 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1737953/000110465918054279/0001104659-18-054279-index.htm |
| 2018-08-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737953/000110465918054285/0001104659-18-054285-index.htm |
| 2018-11-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1737953/000110465918068434/0001104659-18-068434-index.htm |
| 2018-11-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737953/000110465918068443/0001104659-18-068443-index.htm |
| 2018-12-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465918073330/0001104659-18-073330-index.htm |
| 2019-02-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1737953/000110465919008435/0001104659-19-008435-index.htm |
| 2019-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1737953/000110465919008707/0001104659-19-008707-index.htm |
| 2019-02-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737953/000110465919008840/0001104659-19-008840-index.htm |
| 2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465919019704/0001104659-19-019704-index.htm |
| 2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465919019705/0001104659-19-019705-index.htm |
| 2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465919019706/0001104659-19-019706-index.htm |
| 2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465919019707/0001104659-19-019707-index.htm |
| 2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465919019709/0001104659-19-019709-index.htm |
| 2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465919019710/0001104659-19-019710-index.htm |
| 2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465919019715/0001104659-19-019715-index.htm |
| 2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465919019720/0001104659-19-019720-index.htm |
| 2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465919019721/0001104659-19-019721-index.htm |
| 2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465919019723/0001104659-19-019723-index.htm |
| 2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465919019724/0001104659-19-019724-index.htm |
| 2019-04-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465919019727/0001104659-19-019727-index.htm |
| 2019-06-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737953/000110465919035382/0001104659-19-035382-index.htm |
| 2019-06-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737953/000110465919038287/0001104659-19-038287-index.htm |
| 2019-07-29 | 10-K/A | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1737953/000110465919042098/0001104659-19-042098-index.htm |
| 2019-08-07 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1737953/000110465919044553/0001104659-19-044553-index.htm |
| 2019-08-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737953/000110465919044947/0001104659-19-044947-index.htm |
| 2019-08-14 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1737953/000110465919045938/0001104659-19-045938-index.htm |
| 2019-08-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737953/000110465919045944/0001104659-19-045944-index.htm |
| 2019-08-15 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1737953/000110465919046124/0001104659-19-046124-index.htm |
| 2019-09-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737953/000110465919049527/0001104659-19-049527-index.htm |
| 2019-09-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465919051350/0001104659-19-051350-index.htm |
| 2019-09-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465919051354/0001104659-19-051354-index.htm |
| 2019-09-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465919051355/0001104659-19-051355-index.htm |
| 2019-10-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737953/000110465919053935/0001104659-19-053935-index.htm |
| 2019-11-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465919059505/0001104659-19-059505-index.htm |
| 2019-11-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465919059509/0001104659-19-059509-index.htm |
| 2019-11-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465919059510/0001104659-19-059510-index.htm |
| 2019-11-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465919060673/0001104659-19-060673-index.htm |
| 2019-11-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465919060674/0001104659-19-060674-index.htm |
| 2019-11-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465919060675/0001104659-19-060675-index.htm |
| 2019-11-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737953/000110465919061729/0001104659-19-061729-index.htm |
| 2019-11-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465919061830/0001104659-19-061830-index.htm |
| 2019-11-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465919061831/0001104659-19-061831-index.htm |
| 2019-11-08 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465919061832/0001104659-19-061832-index.htm |
| 2019-11-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1737953/000110465919062207/0001104659-19-062207-index.htm |
| 2019-11-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737953/000110465919062211/0001104659-19-062211-index.htm |
| 2019-11-14 | FWP | Filing under Securities Act Rules 163/433 of free writing prospectuses | https://www.sec.gov/Archives/edgar/data/1737953/000110465919063572/0001104659-19-063572-index.htm |
| 2019-11-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737953/000110465919064897/0001104659-19-064897-index.htm |
| 2019-11-25 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1737953/000110465919067100/0001104659-19-067100-index.htm |
| 2019-12-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737953/000110465919071037/0001104659-19-071037-index.htm |
| 2019-12-11 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465919071919/0001104659-19-071919-index.htm |
| 2019-12-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465919071921/0001104659-19-071921-index.htm |
| 2019-12-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465919074340/0001104659-19-074340-index.htm |
| 2019-12-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465919075616/0001104659-19-075616-index.htm |
| 2019-12-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737953/000110465919075653/0001104659-19-075653-index.htm |
| 2020-01-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737953/000110465920002849/0001104659-20-002849-index.htm |
| 2020-01-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737953/000110465920004310/0001104659-20-004310-index.htm |
| 2020-02-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1737953/000110465920019880/0001104659-20-019880-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1737953/000110465920020459/0001104659-20-020459-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1737953/000110465920020955/0001104659-20-020955-index.htm |
| 2020-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465920021648/0001104659-20-021648-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1737953/000110465920021828/0001104659-20-021828-index.htm |
| 2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465920024250/0001104659-20-024250-index.htm |
| 2020-04-02 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465920042493/0001104659-20-042493-index.htm |
| 2020-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465920042496/0001104659-20-042496-index.htm |
| 2020-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465920042499/0001104659-20-042499-index.htm |
| 2020-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465920042500/0001104659-20-042500-index.htm |
| 2020-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465920042501/0001104659-20-042501-index.htm |
| 2020-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465920042502/0001104659-20-042502-index.htm |
| 2020-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465920042504/0001104659-20-042504-index.htm |
| 2020-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465920042506/0001104659-20-042506-index.htm |
| 2020-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465920042507/0001104659-20-042507-index.htm |
| 2020-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465920042508/0001104659-20-042508-index.htm |
| 2020-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465920042509/0001104659-20-042509-index.htm |
| 2020-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465920042511/0001104659-20-042511-index.htm |
| 2020-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465920042512/0001104659-20-042512-index.htm |
| 2020-04-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465920042513/0001104659-20-042513-index.htm |
| 2020-04-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737953/000110465920043704/0001104659-20-043704-index.htm |
| 2020-06-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737953/000110465920069222/0001104659-20-069222-index.htm |
| 2020-06-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737953/000110465920069223/0001104659-20-069223-index.htm |
| 2020-06-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737953/000110465920070829/0001104659-20-070829-index.htm |
| 2020-06-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737953/000110465920072032/0001104659-20-072032-index.htm |
| 2020-07-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737953/000110465920079316/0001104659-20-079316-index.htm |
| 2020-07-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465920082857/0001104659-20-082857-index.htm |
| 2020-07-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737953/000110465920085399/0001104659-20-085399-index.htm |
| 2020-07-22 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465920085401/0001104659-20-085401-index.htm |
| 2020-07-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465920085403/0001104659-20-085403-index.htm |
| 2020-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1737953/000110465920091744/0001104659-20-091744-index.htm |
| 2020-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737953/000110465920091998/0001104659-20-091998-index.htm |
| 2020-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737953/000110465920091999/0001104659-20-091999-index.htm |
| 2020-08-11 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/1737953/000110465920093335/0001104659-20-093335-index.htm |
| 2020-08-11 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737953/000110465920093357/0001104659-20-093357-index.htm |
| 2020-08-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465920096575/0001104659-20-096575-index.htm |
| 2020-08-25 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/1737953/000110465920098397/0001104659-20-098397-index.htm |
| 2020-08-25 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/1737953/000110465920098406/0001104659-20-098406-index.htm |
| 2020-09-01 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465920101464/0001104659-20-101464-index.htm |
| 2020-09-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737953/000110465920103933/0001104659-20-103933-index.htm |
| 2020-09-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465920106117/0001104659-20-106117-index.htm |
| 2020-10-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737953/000110465920114973/0001104659-20-114973-index.htm |
| 2020-10-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465920115710/0001104659-20-115710-index.htm |
| 2020-10-19 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737953/000110465920116131/0001104659-20-116131-index.htm |
| 2020-10-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737953/000110465920116455/0001104659-20-116455-index.htm |
| 2020-10-20 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1737953/000110465920116472/0001104659-20-116472-index.htm |
| 2020-10-21 | FWP | Filing under Securities Act Rules 163/433 of free writing prospectuses | https://www.sec.gov/Archives/edgar/data/1737953/000110465920116817/0001104659-20-116817-index.htm |
| 2020-10-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737953/000110465920116888/0001104659-20-116888-index.htm |
| 2020-10-23 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1737953/000110465920117737/0001104659-20-117737-index.htm |
| 2020-10-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737953/000110465920117740/0001104659-20-117740-index.htm |
| 2020-11-03 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465920120931/0001104659-20-120931-index.htm |
| 2020-11-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000110465920120937/0001104659-20-120937-index.htm |
| 2020-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1737953/000110465920121600/0001104659-20-121600-index.htm |
| 2020-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1737953/000110465920121601/0001104659-20-121601-index.htm |
| 2020-11-05 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/1737953/000110465920121614/0001104659-20-121614-index.htm |
| 2018-07-25 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1737953/000114420418039732/0001144204-18-039732-index.htm |
| 2018-07-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000114420418039736/0001144204-18-039736-index.htm |
| 2019-01-23 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1737953/000114420419002474/0001144204-19-002474-index.htm |
| 2019-02-13 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1737953/000114420419007204/0001144204-19-007204-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1737953/000114420419008077/0001144204-19-008077-index.htm |
| 2019-11-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000117911019011905/0001179110-19-011905-index.htm |
| 2018-08-01 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1737953/000119312518234955/0001193125-18-234955-index.htm |
| 2019-02-13 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1737953/000119312519037827/0001193125-19-037827-index.htm |
| 2019-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1737953/000119312519039811/0001193125-19-039811-index.htm |
| 2020-02-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1737953/000119312520031495/0001193125-20-031495-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1737953/000119312520037541/0001193125-20-037541-index.htm |
| 2019-02-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000120919119010172/0001209191-19-010172-index.htm |
| 2019-11-20 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000120919119057473/0001209191-19-057473-index.htm |
| 2019-11-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000120919119057475/0001209191-19-057475-index.htm |
| 2020-06-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000120919120037603/0001209191-20-037603-index.htm |
| 2020-07-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000120919120041517/0001209191-20-041517-index.htm |
| 2020-09-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1737953/000120919120050942/0001209191-20-050942-index.htm |
| 2020-06-19 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1737953/000138713120005813/0001387131-20-005813-index.htm |
| 2020-07-07 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1737953/000138713120006203/0001387131-20-006203-index.htm |
| 2020-09-17 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/1737953/000138713120008366/0001387131-20-008366-index.htm |
| 2019-08-15 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1737953/999999999519001896/9999999995-19-001896-index.htm |
| 2020-08-26 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/1737953/999999999520002265/9999999995-20-002265-index.htm |
Replimune Group, Inc (REPL) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Replimune Group, Inc (REPL). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 941%Institutional Ownership: 7793%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-09-15 | Colin Love | Chief Operating Officer | Sell | 1,529.00 | 24.83 | 37,965.07 | 1,021,524.00 | https://www.sec.gov/Archives/edgar/data/1737953/000110465920106117/0001104659-20-106117-index.htm |
| 2020-09-15 | Colin Love | Chief Operating Officer | Sell | 10,271.00 | 24.11 | 247,633.81 | 1,023,053.00 | https://www.sec.gov/Archives/edgar/data/1737953/000110465920106117/0001104659-20-106117-index.htm |
| 2020-09-15 | Colin Love | Chief Operating Officer | Sell | 3,200.00 | 23.09 | 73,888.00 | 1,033,324.00 | https://www.sec.gov/Archives/edgar/data/1737953/000110465920106117/0001104659-20-106117-index.htm |
| 2020-08-17 | Colin Love | Chief Operating Officer | Sell | 5,964.00 | 23.19 | 138,305.16 | 1,036,524.00 | https://www.sec.gov/Archives/edgar/data/1737953/000110465920096575/0001104659-20-096575-index.htm |
| 2020-08-17 | Colin Love | Chief Operating Officer | Sell | 9,036.00 | 23.60 | 213,249.60 | 1,042,488.00 | https://www.sec.gov/Archives/edgar/data/1737953/000110465920096575/0001104659-20-096575-index.htm |
| 2019-11-06 | Colin Love | Chief Operating Officer | Sell | 11,250.00 | 17.00 | 191,250.00 | 1,051,524.00 | https://www.sec.gov/Archives/edgar/data/1737953/000110465919061832/0001104659-19-061832-index.htm |
| 2019-11-06 | Colin Love | Chief Operating Officer | Sell | 11,250.00 | 17.02 | 191,475.00 | 1,062,774.00 | https://www.sec.gov/Archives/edgar/data/1737953/000110465919061832/0001104659-19-061832-index.htm |
| 2019-11-04 | Colin Love | Chief Operating Officer | Sell | 11,250.00 | 17.00 | 191,250.00 | 1,074,024.00 | https://www.sec.gov/Archives/edgar/data/1737953/000110465919060674/0001104659-19-060674-index.htm |
| 2019-11-04 | Colin Love | Chief Operating Officer | Sell | 11,250.00 | 17.05 | 191,835.00 | 1,085,274.00 | https://www.sec.gov/Archives/edgar/data/1737953/000110465919060674/0001104659-19-060674-index.htm |
| 2019-10-31 | Colin Love | Chief Operating Officer | Sell | 11,250.00 | 17.00 | 191,250.00 | 1,096,524.00 | https://www.sec.gov/Archives/edgar/data/1737953/000110465919059505/0001104659-19-059505-index.htm |
| 2019-11-18 | Jason P Rhodes | Director | Buy | 1,100,000.00 | 13.61 | 14,971,000.00 | 1,100,000.00 | https://www.sec.gov/Archives/edgar/data/1737953/000120919119057475/0001209191-19-057475-index.htm |
| 2019-09-23 | Colin Love | Chief Operating Officer | Sell | 11,250.00 | 17.05 | 191,812.50 | 1,107,774.00 | https://www.sec.gov/Archives/edgar/data/1737953/000110465919051354/0001104659-19-051354-index.htm |
| 2019-12-20 | Pamela Esposito | Chief Business Officer | Buy | 25,700.00 | 1.75 | 44,975.00 | 112,700.00 | https://www.sec.gov/Archives/edgar/data/1737953/000110465919075616/0001104659-19-075616-index.htm |
| 2020-08-31 | Pamela Esposito | Chief Business Officer | Sell | 5,000.00 | 27.05 | 135,250.00 | 112,700.00 | https://www.sec.gov/Archives/edgar/data/1737953/000110465920101464/0001104659-20-101464-index.htm |
| 2020-10-14 | Pamela Esposito | Chief Business Officer | Sell | 9,000.00 | 35.04 | 315,360.00 | 112,700.00 | https://www.sec.gov/Archives/edgar/data/1737953/000110465920115710/0001104659-20-115710-index.htm |
| 2020-08-31 | Pamela Esposito | Chief Business Officer | Buy | 5,000.00 | 1.01 | 5,050.00 | 117,700.00 | https://www.sec.gov/Archives/edgar/data/1737953/000110465920101464/0001104659-20-101464-index.htm |
| 2020-10-14 | Pamela Esposito | Chief Business Officer | Sell | 7,000.00 | 30.15 | 211,050.00 | 121,700.00 | https://www.sec.gov/Archives/edgar/data/1737953/000110465920115710/0001104659-20-115710-index.htm |
| 2020-10-14 | Pamela Esposito | Chief Business Officer | Buy | 16,000.00 | 1.01 | 16,160.00 | 128,700.00 | https://www.sec.gov/Archives/edgar/data/1737953/000110465920115710/0001104659-20-115710-index.htm |
| 2019-11-06 | Philip Astley-Sparke | Executive Chairman | Sell | 14,500.00 | 17.00 | 246,500.00 | 1,355,297.00 | https://www.sec.gov/Archives/edgar/data/1737953/000110465919061831/0001104659-19-061831-index.htm |
| 2019-11-06 | Philip Astley-Sparke | Executive Chairman | Sell | 14,500.00 | 17.02 | 246,790.00 | 1,369,797.00 | https://www.sec.gov/Archives/edgar/data/1737953/000110465919061831/0001104659-19-061831-index.htm |
| 2019-11-04 | Philip Astley-Sparke | Executive Chairman | Sell | 14,500.00 | 17.00 | 246,500.00 | 1,384,297.00 | https://www.sec.gov/Archives/edgar/data/1737953/000110465919060675/0001104659-19-060675-index.htm |
| 2019-11-04 | Philip Astley-Sparke | Executive Chairman | Sell | 14,500.00 | 17.05 | 247,254.00 | 1,398,797.00 | https://www.sec.gov/Archives/edgar/data/1737953/000110465919060675/0001104659-19-060675-index.htm |
| 2019-10-31 | Philip Astley-Sparke | Executive Chairman | Sell | 14,500.00 | 17.00 | 246,500.00 | 1,413,297.00 | https://www.sec.gov/Archives/edgar/data/1737953/000110465919059509/0001104659-19-059509-index.htm |
| 2019-09-23 | Philip Astley-Sparke | Executive Chairman | Sell | 14,500.00 | 17.05 | 247,225.00 | 1,427,797.00 | https://www.sec.gov/Archives/edgar/data/1737953/000110465919051355/0001104659-19-051355-index.htm |
| 2020-07-09 | Robert Coffin | President & Chief R&D Officer | Sell | 24,250.00 | 21.02 | 509,735.00 | 2,024,118.00 | https://www.sec.gov/Archives/edgar/data/1737953/000110465920082857/0001104659-20-082857-index.htm |
| 2020-07-09 | Robert Coffin | President & Chief R&D Officer | Sell | 145,500.00 | 22.32 | 3,247,560.00 | 2,048,368.00 | https://www.sec.gov/Archives/edgar/data/1737953/000110465920082857/0001104659-20-082857-index.htm |
| 2020-02-20 | Robert Coffin | Pres & Chief Res & Dev Officer | Sell | 24,250.00 | 17.04 | 413,220.00 | 2,193,868.00 | https://www.sec.gov/Archives/edgar/data/1737953/000110465920024250/0001104659-20-024250-index.htm |
| 2020-02-12 | Robert Coffin | Pres & Chief Res & Dev Officer | Sell | 24,250.00 | 17.03 | 412,977.50 | 2,218,118.00 | https://www.sec.gov/Archives/edgar/data/1737953/000110465920021648/0001104659-20-021648-index.htm |
| 2020-02-12 | Robert Coffin | Pres & Chief Res & Dev Officer | Sell | 24,250.00 | 17.04 | 413,220.00 | 2,242,368.00 | https://www.sec.gov/Archives/edgar/data/1737953/000110465920021648/0001104659-20-021648-index.htm |
| 2019-11-06 | Robert Coffin | President and CEO | Sell | 24,250.00 | 17.00 | 412,250.00 | 2,266,618.00 | https://www.sec.gov/Archives/edgar/data/1737953/000110465919061830/0001104659-19-061830-index.htm |
| 2019-11-06 | Robert Coffin | President and CEO | Sell | 24,250.00 | 17.02 | 412,735.00 | 2,290,868.00 | https://www.sec.gov/Archives/edgar/data/1737953/000110465919061830/0001104659-19-061830-index.htm |
| 2019-11-04 | Robert Coffin | President and CEO | Sell | 24,250.00 | 17.00 | 412,250.00 | 2,315,118.00 | https://www.sec.gov/Archives/edgar/data/1737953/000110465919060673/0001104659-19-060673-index.htm |
| 2019-11-04 | Robert Coffin | President and CEO | Sell | 24,250.00 | 17.05 | 413,511.00 | 2,339,368.00 | https://www.sec.gov/Archives/edgar/data/1737953/000110465919060673/0001104659-19-060673-index.htm |
| 2019-10-31 | Robert Coffin | President and CEO | Sell | 24,250.00 | 17.00 | 412,250.00 | 2,363,618.00 | https://www.sec.gov/Archives/edgar/data/1737953/000110465919059510/0001104659-19-059510-index.htm |
| 2019-09-23 | Robert Coffin | President and CEO | Sell | 24,250.00 | 17.05 | 413,462.50 | 2,387,868.00 | https://www.sec.gov/Archives/edgar/data/1737953/000110465919051350/0001104659-19-051350-index.htm |
| 2018-07-24 | Omega Fund IV, L.P. | 10% Share Holder | Buy | 266,667.00 | 15.00 | 4,000,005.00 | 266,667.00 | https://www.sec.gov/Archives/edgar/data/1737953/000089924318020583/0000899243-18-020583-index.htm |
| 2018-07-24 | Bain Capital Life Sciences Investors, LLC | 10% Share Holder | Buy | 500,000.00 | 15.00 | 7,500,000.00 | 2,838,968.00 | https://www.sec.gov/Archives/edgar/data/1737953/000089924318020659/0000899243-18-020659-index.htm |
| 2018-07-24 | Capital Fund III Cooperatief U.A. Forbion | 10% Share Holder | Buy | 133,333.00 | 15.00 | 1,999,995.00 | 4,721,449.00 | https://www.sec.gov/Archives/edgar/data/1737953/000110465918047445/0001104659-18-047445-index.htm |
| 2018-07-24 | Hugo Alexander Slootweg | Director | Buy | 133,333.00 | 15.00 | 1,999,995.00 | 4,721,449.00 | https://www.sec.gov/Archives/edgar/data/1737953/000110465918047460/0001104659-18-047460-index.htm |
| 2019-11-18 | Omega Fund IV, L.P. | 10% Share Holder | Buy | 220,000.00 | 13.61 | 2,994,200.00 | 5,328,939.00 | https://www.sec.gov/Archives/edgar/data/1737953/000117911019011905/0001179110-19-011905-index.htm |
| 2019-11-26 | Howard Kaufman | Chief Medical Officer | Buy | 58,067.00 | 3.30 | 191,621.10 | 58,067.00 | https://www.sec.gov/Archives/edgar/data/1737953/000110465919074340/0001104659-19-074340-index.htm |
| 2018-07-24 | JOSEPH P SLATTERY | Director | Buy | 6,667.00 | 15.00 | 100,005.00 | 6,667.00 | https://www.sec.gov/Archives/edgar/data/1737953/000110465918047446/0001104659-18-047446-index.htm |
| 2018-12-13 | Pamela Esposito | Chief Business Officer | Buy | 87,000.00 | 1.75 | 152,250.00 | 87,000.00 | https://www.sec.gov/Archives/edgar/data/1737953/000110465918073330/0001104659-18-073330-index.htm |